Fate Therapeutics
FATE
FATE
137 hedge funds and large institutions have $88.8M invested in Fate Therapeutics in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% more funds holding
Funds holding: 131 → 137 (+6)
14.77% less ownership
Funds ownership: 84.17% → 69.4% (-15%)
Holders
137
Holding in Top 10
–
Calls
$264K
Puts
$40K
Top Buyers
| 1 | +$656K | |
| 2 | +$467K | |
| 3 | +$304K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$298K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$296K |
Top Sellers
| 1 | -$7.98M | |
| 2 | -$3.88M | |
| 3 | -$1.79M | |
| 4 |
O
OrbiMed
New York
|
-$1.33M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.15M |